In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative.
In an effort to get to the root of healthcare spending in the United States, the National Pharmaceutical Council launched the Going Below the Surface initiative. In addition to examining the drivers of healthcare spending, the initiative is creating a national multistakeholder dialogue to determine best practices for optimizing spending.
Today, we speak with Bobby Dubois, MD, PhD, chief science officer and executive vice president, National Pharmaceutical Council, about the initiative, its goals, and what it has found so far.
To listen to the podcast, please login.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or or through one of these podcast services:
Learn more about drug prices in the United States and efforts to lower them:
From Patient Advocates to Pharma, Groups Weigh in on Trump Blueprint for Drug Costs
Healthcare Spending Driven by Price, Not Utilization: JAMA Study
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
A Look at the Legal and Legislative Landscape Impacting Drug Costs for Patients
October 23rd 2024Kimberly Westrich, MA, of National Pharmaceutical Council, and Adam Colborn, JD, of AMCP, run through the current status of lawsuits and lawmaking at the federal and state levels related to pharmacy benefit managers and cost-shifting programs.
Read More